Abstract
The present study investigated the effect of the angiotensin-converting enzyme (ACE) inhibitors, captopril, CGS14824A and CGS14831 onin vitro rat aortic and urinary bladder prostacyclin (PGI2; measured as 6-oxo-PGF1α by radioimmunoassay) synthesis. PGI2 synthesis was stimulated with adrenaline (aorta), carbachol (bladder), calcium ionophore A23187, arachidonate and trauma. The ACE inhibitors antagonised adrenaline-, carbachol- and A23187-stimulated PGI2 synthesis in the aorta and bladder (CGS14824A>captopril>CGS14831) but were without effect on trauma- or arachidonate-stimulated PGI2 synthesis. The patterns of inhibition of these ACE inhibitors, using the same stimulatory regimes, was very similar to those previously observed by us with known calcium channel blockers (nifedipine, verapamil). These data suggest that: (i) ACE inhibitors possess calcium channel blocking properties, which may be of relevance to the antihypertensive action of these drugs; and (ii) ACE inhibitors did not stimulate vascular PGI2 synthesis as has been previously suggested.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
F. R. Crantz, S. L. Swartz, T. J. Hollenberg et al.,Role of prostaglandins in the hypotensive response to captopril in essential hypertension. Clin Res27, 592A (1979).
R. G. Dluhy and T. J. Moore,Captopril-induced changes in prostaglandin production. J. Clin. Invest.65, 1257–1264 (1980).
D. J. Dusting, E. M. Mullins and A. E. Doyle,Angiotensin-induced prostacyclin release may contribute to the hypotensive action of converting enzyme inhibitors. Advances in Prostaglandin and Thromboxane Research7, 815–819 (1980).
H. Gavras, H. R. Brunner, G. A. Turini et al.,Antihypertensive effect of the oral angiotensin converting enzyme inhibitor SQ 14,225 in man, N. Engl. J. Med.298, 991–995 (1978).
M. S. Golub, M. E. Berger and A. E. Carnazzola,Adrenergic stimulation of prostacyclin synthesis by the rat tail artery. II. The role of calcium. Prostagl. Leukotr. Med.20, 313–324 (1985).
A. Hornych, M. Safar, A. Simon, J. Levenson, J. Bariety and P. Milliez,Effects of captopril on prostaglandins and natriuresis in patients with essential hypertension. Am. J. Cardiol.49, 1524–2526 (1982).
R. F. Irvine,How is the level of free arachidonic acid controlled in mammalian cells. Biochem. J.204, 3–14 (1982).
I. M. James, E. J. Dickenson, W. Burgoyne, J. Y. Jeremy, M. A. Barradas, D. P. Mikhailidis and P. Dandona,Treatment of hypertension with captopril: preservation of regional blood flow and reduced platelet aggregation. J. Human Hypertension (in press).
J. Y. Jerremy and P. Dandona,Inhibition by hydrocortisone of prostacyclin synthesis by rat aorta and its reversal with RU486. Endocrinol.119, 661–665 (1986).
J. Y. Jeremy and P. Dandona,Inhibition by hydrocortisone of prostacyclin synthesis by rat aorta and its reversal with RU486, Endocrinol.119, 661–665 (1986).
J. Y. Jeremy, D. P. Mikhailidis and P. Dandona,Vascular trauma and prostacyclin release. Microcircul. Endothel. Lymph.1, 629–644 (1984a).
J. Y. Jeremy, D. P. Mikhailidis and P. Dandona,Urinary bladder synthesises prostacyclin as well as other prostanoids. Prostagl. Leukotr. Med.16, 235–248 (1984b).
J. Y. Jeremy, D. P. Mikhailidis and P. Dandona,Adrenergic modulation of vascular prostacylin synthesis. Eur. J. Pharmacol.114, 33–40 (1985a).
J. Y. Jeremy, M. A. Barradas, D. P. Mikhailidis and P. Dandona,An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis. Drugs Under Clin. Exper. Res.11, 645–651 (1985b).
J. Y. Jeremy, D. P. Mikhailidis and P. Dandona,Effect of nifedipine, nimodipine and nisoldipine on agonist and traumastimulated rat aortic prostacyclin synthesis in vitro. Naunyn Schmiedeberg's Arch Pharmacol.332, 70–73 (1986a).
J. Y. Jeremy, D. P. Mikhailidis and P. Dandona,Prostanoid synthesis by the rat urinary bladder: evidence for stimulation through muscarine receptor-linked channels. Naunyn Schmiedeberg's Arch Pharmacol.334, 463–467 (1986b).
K. M. Mullane, S. Moncada,Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment. Eur. J. Pharmacol.66, 355–365 (1980).
A. A. Patchett, E. Harris, E. W. Tristram et al.,A new class of angiotensin-converting enzyme inhibitors. Nature288, 280–283 (1980).
N. Someya, K. Kodama and K. Tanaka,Effect of captopril on plasma prostacyclin concentration in essential hypertensive patients, Prostagl. Leukotr. Med.20, 187–195 (1985).
D. Stewart, E. Poutney and D. Fitchett,Norepinephrine-stimulated vascular prostacyclin synthesis. Receptor-dependent calcium channels control prostaglandin synthesis. Can. J. Physiol. Pharmacol.62, 1341–1347 (1984).
A. L. Swartz and G. H. Williams,Angiotensin converting enzyme inhibition and prostaglandins. Am. J. Cardiol.49, 1405–1409 (1982).
P. A. van Zwieten, M. J. Mathy, M. J. M. C. Thoolen, B. Wilffert, A. de Jonge and P. B. M. W. M. Timmermans,Effects of urapidil on blood pressure and adrenoceptors in various animal models. J. Hypertension.2, (Suppl. 3), 539–541 (1984).
P. H. Vlasses, R. K. Ferguson, J. B. Smith, H. H. Rotmensch, B. N. Swanson,Urinary excretion of prostacyclin and thromboxane A 2 metabolites after angiotensin converting enzyme inhibition in hypertensive patients. Prostagl. Leukotr. Med.11, 143–150 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jeremy, J.Y., Mikhailidis, D.P. & Dandona, P. Angiotensin converting enzyme inhibitors (captopril, CGS14831 and CGS14824A) antagonisein vitro smooth muscle prostanoid synthesis: evidence for calcium channel blockade. Agents and Actions 24, 381–386 (1988). https://doi.org/10.1007/BF02028297
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02028297